IMO engaged HGP to assess strategic opportunities to accelerate their Natural Language Processing (NLP) capabilities. The acquisition of Melax Tech will enhance IMO’s portfolio of healthcare data solutions and enable IMO to expand its offerings to various segments in the healthcare market to tackle diverse problems like improving clinical and administrative workflows, clinical research, and patient outcomes.
HGP supported IMO in the transaction, which aligns with IMO's mission to help physicians document care in their own words while capturing the right codes behind the scenes. HGP is proud to have supported and advised IMO through the company's first acquisition.
symplr's Spend Management product suite will be strengthened by adding GreenLight's quality and value-based purchasing decision support capabilities, together offering one of the most comprehensive spend management and value analysis SaaS solutions in the industry.
HGP supported symplr in the transaction, which aligns with symplr's mission to deliver streamlined supply chain decision support for healthcare systems. HGP has served as financial and strategic advisor to symplr since 2014, with GreenLight Medical representing the 10th buy-side acquisition advised by HGP.
nThrive, a comprehensive RCM platform provider, engaged HGP to assess strategic opportunities to execute on their buy-and-build thesis. Patient access and digital patient intake were identified as highly strategic extensions that advance nThrive's position as a leading provider in front-end revenue cycle management.
HGP supported nThrive in the transaction, which extends nThrive's leadership in revenue cycle management by adding innovative patient access offerings and new capabilities to support digital patient intake and patient engagement.
Clinical communications was identified as a highly strategic extension for symplr's product suite, further streamlining clinical processes and interactions, and improving clinical satisfaction and patient care.
HGP supported symplr in the transaction, which bolsters symplr's rapidly growing workforce and talent management portfolio with the addition of clinical communications. HGP has served as financial and strategic advisor to symplr in since 2014, with Halo representing the 9th buy-side acquisition advised by HGP.
The symplr team identified physician scheduling as a key product offering to further build out their comprehensive suite of workforce management offerings that enable healthcare organizations to better optimize staff.
Through extensive strategic landscaping, HGP identified SpinFusion as a compelling platform that would fulfill symplr's need for a provider scheduling solution and supported the Company in the acquisition.
Imprivata, the digital identity platform for healthcare, sought to expand their protection platform and access management capabilities to better serve healthcare and other organizations whose security and privacy needs are growing.
HGP identified Xton Technologies as an optimal acquisition target whose privileged access management solutions will fortify Imprivata's existing digital identity framework by safeguarding and controlling access to a broader set of mission-critical resources and data.
Millennia, a leader in patient payment solutions for hospitals, health systems and medical groups, has acquired Jellyfish Health, an innovative provider of patient engagement and patient access software.
HGP identified a proprietary transaction for Millennia, widening their array of patient access solutions and offering a more comprehensive patient experience suite.
As the global healthcare GRC leader, symplr has been focused on driving consolidation in the industry and accelerating growth via strategic acquisitions. HGP has served as financial and strategic advisor to symplr in varying capacities since 2014, with Phynd representing the 7th buy-side acquisition advised by HGP.
HGP identified Phynd as an ideal acquisition target for enhancing symplr's provider data management offering to enable management of a provider's profile, location, clinical expertise, health plan and network participation, and programs.
Ontellus is the industry leading provider of records retrieval, supporting the entire supply chain of records procurement through data analysis. HGP was engaged to support inorganic growth initiatives to continue growing the Ontellus ecosystem of record retrieval solutions.
HGP is a long-term buy-side advisor of Ontellus and identified Intertel as an ideal medical canvassing acquisition target to expand the Ontellus solutions offering.
symplr, a leading healthcare governance, risk and compliance SaaS platform sought to expand their GRC capabilities by adding issue and action management, incident management, contract and document management, and audit management SaaS solutions.
Growth through acquisition is an integral part of symplr's business strategy to deliver the industry’s leading healthcare GRC SaaS platform and HGP supported the company through their ninth acquisition.
symplr, a leading healthcare governance, risk and compliance SaaS platform sought to expand their capabilities to address the full spectrum of healthcare labor regulatory requirements.
HGP identified TPSC as an ideal acquisition target for symplr that would enable them to include patient safety and incident tracking and reporting in their end-to-end GRC platform.
Accumen Inc., the market leader in healthcare performance improvement across operational, clinical, and data for healthcare, sought to expand their portfolio of capabilities focused on bringing clients meaningful savings, operational efficiencies, and improved patient care.
HGP identified 3DR Laboratories as an ideal acquisition for Accumen in further strengthening the imaging transformation service line within the Clinical Performance Business Unit. 3DR is known for high-quality and consistent expert processing, enabling radiologists to meet even the most urgent patient needs. The combined organization will continue to build on an already strong imaging transformation offering to aid clients in achieving and exceeding their cost, quality, and service targets.
Omnisys, a nationally recognized leader in medical claim billing, Medicare compliance and patient engagement solutions for pharmacies, HME/DME providers and pharmaceutical manufacturers, engaged HGP to assess strategic acquisition opportunities to enhance their product portfolio.
HGP identified STRAND Clinical Technologies as an ideal acquisition for Omnisys in their shared mission to leverage the pharmacy setting to improve patient outcomes. The combined entity will provide a suite of technologies and tools to support the pharmacy's role in care delivery, enabling community pharmacists to provide preventative care and low-acuity services traditionally performed in a doctor's office.
Ontellus is a record retrieval vendor, which HGP advised on its recapitalization with CapStreet and continued to serve as long-term buy-side advisor.
HGP landscaped the market and has supported Ontellus through its fourth acquisition.
symplr was looking for a strategic acquisition to enter the provider data management space to complement its existing healthcare compliance and credentialing solutions.
As a long-term buy-side advisor for symplr, HGP helped identify new market verticals and navigate discussions with companies in each to arrive at an excellent strategic fit with Vistar. This is the fourth strategic acquisition symplr has completed with HGP.
Omnisys, a nationally recognized leader in medical claim billing, Medicare compliance and patient engagement solutions for pharmacies, HME/DME providers and pharmaceutical manufacturers, engaged HGP to assess strategic acquisition opportunities to enhance their product portfolio.
HGP identified a proven SaaS patient communication and adherence platform in voiceTech. The combined entity will deliver added value to its pharmacy customers and the patients they serve through its newly expanded set of solutions for pharmacies.
Keais is a medical record retrieval vendor serving insurance carriers and law firms.
After advising Keais on a majority recap, Keais retained HGP to identify and execute on strategic acquisitions, resulting in multiple acquisitions that drove significant returns for investors and management.
Lightbeam is a population health management software vendor that HGP supported through multiple rounds of institutional and strategic capital.
HGP served as strategic advisor in the acquisition of Browsersoft, an HIE vendor serving the provider market.
HGP served as a long-term buy-side advisor to symplr, a compliance and credentialing vendor. HGP advised symplr on two acquisitions, resulting in a successful recap, and, by leveraging fresh equity, the acquisition of Cactus.
HGP identified and executed on multiple acquisitions with symplr, all proprietary, resulting in significant returns for management and symplr's private equity partners.
Nextech, a specialty EMR vendor backed by Francisco Parnters, engaged HGP to lead and support its buy-side strategy.
HGP supported Nextech's acquisition of SupraMed, a specialty vendor focused on the plastic surgery practice management.
HGP served as a long-term buy-side advisor to symplr, a compliance and credentialing vendor. HGP advised symplr on two acquisitions, including CBR, prior to a successful recapitalization.
HGP identified and executed on multiple acquisitions with symplr, all proprietary, resulting in significant returns for management and symplr's private equity partners.
HGP closed multiple transactions with Merge, serving as both sell-side and buy-side advisor. Merge, a medical imaging software company, engaged HGP to complete a fairness opinion of DR Systems.
HGP completed the fairness opinion of DR Systems, a medical imaging software vendor.
Net Health is a specialty EMR vendor focused on wound care, urgent care, and PT. A former HGP client stepped in as CEO of Net Health and hired HGP to pursue a recapitalization of the company to position the company for growth and acquisitions.
HGP initiated the process with a strategic review, which included an assessment of strategic alternatives, identification of markets and capabilities to drive growth, and landscaping of acquisition targets, leading to a recap with Spectrum Equity and subsequent acquisitions, including ReDoc.
HGP served as long-term strategic and buy-side advisor to Hearst Health, one of the largest providers of clinical content to the healthcare industry.
HGP supported Hearst through multiple stages of the buy-side process resulting in the acquisition of care guidelines vendor, Milliman Care Guidelines.
HGP served as sell-side advisor to MedHost in its sale to HealthTech Holdings (backed by Primus), which subsequently renamed itself MedHost.
Knowing MedHost's strategic need to acquire a high acuity surgery management vendor, HGP identified and supported the proprietary acquisition of Acuitec.
HGP begins each buy-side assignment with an intensive strategic review process designed to align the acquisition strategy with long-term shareholder objectives. Following completion of the initial strategic review, market assessment, and market mapping, HGP executes on the vision by identifying and pursuing acquisition targets. HGP dynamically reevaluates and refreshes the acquisition and strategic vision based on discovery from the process itself, which may be utilized to position a buyer for its own future liquidity event. Additionally, HGP offers Fairness Opinions to help satisfy the fiduciary duties placed on the board of the acquirer. HGP has experienced high success rates in identifying and closing proprietary transactions that achieve objectives of both the buyer and seller, resulting in strong returns for our clients.